-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Comprehensive Transcriptional Analysis of Early Stage Urothelial Carcinoma using whole transcriptome sequencing
Study
EGAS00001001236
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Phased melanoma whole genomes
Dataset
EGAD00001005773
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Multiomic profiling of early-passage melanoma cell lines.
Study
EGAS00001004536
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871